Abstract Number: 2298 • 2013 ACR/ARHP Annual Meeting
Upper-Half Serum IgA (20+ TU/ml) and IgM (10+ IU/ml) Levels Significantly Predicted The Long-Term (mean 12 yrs) Onset Of Rheumatoid Arthritis When Combined, But Neither test Individually In Their Respective Full Ranges Of Values
Background/Purpose: Serum rheumatoid factor (RF) is a major predictor of the new onset of rheumatoid arthritis (RA). In very early arthritis patients, higher titers…Abstract Number: 2299 • 2013 ACR/ARHP Annual Meeting
Disease Activity Scoring: Comparing Patient and Physician Global Assessment Of Disease Activity In Rhumatoid Arthritis Patients Starting a First Biologic Agent
Background/Purpose: Visual analogue scales (VAS) are routinely used in daily clinical practice and are part of the different composite outcome measures such as the DAS,…Abstract Number: 2300 • 2013 ACR/ARHP Annual Meeting
Rheumatologists Who Are Consistently Using An Objective Outcome Instrument Do Not “Treat To Target” In a Real World Setting
Background/Purpose: The public database JointManTMwas launched January 2012 with a mission to provide a practical outcome tool to manage patients with RA in a clinical…Abstract Number: 2301 • 2013 ACR/ARHP Annual Meeting
T Cell Proliferative Response To Type II Collagen In Patients With Rheumatoid Arthritis
Background/Purpose: To compare the frequency of Collagen II reactive T cells in RA patients and healthy control and evaluating the relationship of Collagen II reactive…Abstract Number: 2302 • 2013 ACR/ARHP Annual Meeting
Anti-Carbamylated Protein Antibody In Japanese Patients With Rheumatoid Arthritis
Background/Purpose: Serology represents a powerful tool for the identification and sub-classification of patients with rheumatoid arthritis (RA). IgM-rheumatoid factor and anti-cyclic citrullinated peptide (CCP) antibodies…Abstract Number: 2303 • 2013 ACR/ARHP Annual Meeting
Clinical Characteristics Of Rheumatoid Factor-Positive Or Negative Subsets Of Anti-Citrullinated Peptide/Protein Antibody-Negative Rheumatoid Arthritis
Background/Purpose: Although anti-citrullinated peptide/protein antibody (ACPA) is a specific autoantibody for rheumatoid arthritis (RA), ~20% of RA are ACPA negative. It has been reported that…Abstract Number: 2304 • 2013 ACR/ARHP Annual Meeting
Follow-Up Of Patients With Preclinical Rheumatoid Arthritis – Results Of a Telephone Survey
Background/Purpose: Preclinical rheumatoid arthritis (pre-RA) describes a subset of patients with arthralgia (but no synovitis) where either anti-citrullinated peptide antibodies (ACPA) and/or rheumatoid factor (RF)…Abstract Number: 2305 • 2013 ACR/ARHP Annual Meeting
Influence Of Disease Activity On The Physical Activity Of Rheumatoid Arthritis Patients
Background/Purpose: It is generally assumed that rheumatoid arthritis (RA) patients tend to exercise less than what is currently recommended. However, there is little data on…Abstract Number: 2306 • 2013 ACR/ARHP Annual Meeting
Comparative Study Of Patients With Peripheral Psoriatic Arthritis, Axial Psoriatic Arthritis and Axial Spondyloarthritis Without Psoriasis
Background/Purpose: Axial involvement in Psoriatic Arthritis (PsA) is reported to be between 40 -70%. Both, axial and peripheral arthritis in patients with PsA can cause…Abstract Number: 2307 • 2013 ACR/ARHP Annual Meeting
Lifestyle Factors Were Seldom Discussed With Patients Visiting a Rheumatology Clinic
Background/Purpose: There is increasing evidence that lifestyle factors are of importance for outcome of rheumatic diseases, and lifestyle interventions should be a natural part of…Abstract Number: 2308 • 2013 ACR/ARHP Annual Meeting
Rheumatoid Arthritis Flares: Inflammatory Or Avalanche?
Background/Purpose: Previous research has not addressed how RA patients' symptoms change daily. The aim of this study was to explore symptom patterns during daily life…Abstract Number: 2309 • 2013 ACR/ARHP Annual Meeting
Quantifying The Gap Between General Population Guidelines and Expert Opinion For Cardiovascular Risk Management In Rheumatic Disease Patients
Background/Purpose: Cardiovascular (CV) risk is higher among rheumatic disease patients than the general population. However, CV risk management guidelines calibrated for the rheumatic disease population…Abstract Number: 2270 • 2013 ACR/ARHP Annual Meeting
US Guided Treat-To-Target Approach In Early RA: Implications For Uncoupling Of Disease Activity and Structural Damage
Background/Purpose: To assess the relationship between inflammation and joint destruction in RA patients who have not responded clinically to treatment using Musculoskeletal US as a…Abstract Number: 2271 • 2013 ACR/ARHP Annual Meeting
Dietary Sodium Increases The Risk For Rheumatoid Arthritis Among Smokers – Results From a Nested Case-Control Study
Background/Purpose: Recent studies using animal models and human cells ex vivo have indicated that sodium chloride may affect the immune system by the inducting of pathogenic Th17…Abstract Number: 2272 • 2013 ACR/ARHP Annual Meeting
Patient Survey Regarding Utility Of The Health Assessment Questionnaire Reveals An Unrecognized Aspect Of Disease Activity In Rheumatoid Arthritis: Consequences Of Physical Activity
Patient Survey Regarding Utility of the Health Assessment Questionnaire Reveals an Unrecognized Aspect of Disease Activity in Rheumatoid Arthritis: Consequences of Physical Activity Background/Purpose: The…
ACR Meeting Abstracts